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In vivo magnetic resonance imaging of the effects of photodynamic
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NMR Unit, University of Manchester Medical School, Manchester M13 9PT, UK.
Summary Nuclear magnetic resonance (NMR) proton imaging and measurements of the parameters T1 and
T2, have been carried out in vivo on the murine mammary tumour T50/80. Tumours had been treated 24h
previously by photodynamic therapy (PDT, using haematoporphyrin derivative and 630nm laser light).
Proton images clearly demarcated a high signal-intensity region on the side of the tumour closest to the
incident light beam, while the parts of the tumour more remote from the beam resembled the images from
untreated controls. Both T, and T2 values were raised in the high-intensity region. This high-intensity region
was shown to correspond to PDT-induced histological necrosis, the low-intensity region to histologically
intact tumour. Linear regression analysis of the relationship of depth of necrosis measured histologically and
'depth of necrosis' measured from the NMR images, yielded a slope of 0.93 (r2=0.95).
There is increasing experimental and clinical interest in
photodynamic therapy (PDT), in which the combination of
visible light and photosensitising drugs produces locally
cytotoxic chemical moieties. A principal mode of action of
PDT in vivo is thought to be acute injury to the vasculature
of both tumours (e.g. Henderson et al., 1985) and normal
tissues (e.g. Berenbaum et al., 1986; Benstead & Moore,
1988). In tumours, vascular collapse leads to prompt and
massive secondary ischaemic necrosis of the malignant cells.
This classical form of cell death is characterised by failure of
large numbers of contiguous cells to maintain homoeostatic
regulation of fluid volume, together with early cessation of
mitochondrial energy metabolism (Trump & Arstila, 1975).
This contrasts with the form of cell death ('apoptosis';
reviewed by Kerr et al., 1987) that occurs after, e.g., ionising
irradiation, where cells die as individuals scattered among
groups of apparently intact, metabolising cells. It appeared
to us that the former type of cell death might offer
opportunities for proton imaging of acute injury to tumours
by PDT. In the current stage of development of PDT, some
form of early monitoring of treatment would be of great
value, as the relationships of delivered PDT 'dose' and
biological effect are not simple. Light 'dose' is commonly
defined in terms of fluence at the tumour surface, while drug
'dose' is almost universally the amount injected into the
animal or patient; the actual quantities of each within
tumours are likely to vary between individuals because of
biological heterogeneity, leading to a variable therapeutic
response. Threshold doses of both light and drug are
required to achieve cell killing. We report here our first
results on the use of NMR in monitoring the effects of PDT
on an experimental mammary tumour.
Materials and methods
Mice
Nine- to 10-week-old male mice of the B6D2F1 strain (the
F1 hybrid of the cross of sib-mated lines C57B16 x DBA2;
Paterson Institute strains) were used. Mice were housed
under a 12h dark (18.00-06.00h), 12h light regimen except
where otherwise noted, and were provided with food and
water ad libitum.
Tumour
Third to 6th passage generations of the mammary carcinoma
T50/80, syngeneic in B6D2F1 mice, were used. Tumours
Received 21 November 1988, and in revised form, 17 March 1989.
were implanted as a brei in the subcutaneous tissues of the
abdominal flank, and used experimentally when they reached
an average depth, normal to the body wall, of 9mm (average
length of 1.5cm).
Photosensitising drug
Haematoporphyrin derivative (HPD; Paisley Biochemicals,
Paisley, Scotland) was obtained and used as a 5mgml-1
solution in 0.9% saline. HPD was injected intraperitoneally
at a well-tolerated dose of 40mgkg-1 and the animals were
kept in the dark for 24h and then treated by laser light. The
dose of drug, which falls within the reciprocity region for
this drug-laser-tumour- effect combination, was selected in
order to minimise the length of laser exposure required to
achieve the biological effect.
Laser irradiation
A 10W copper vapour laser (Oxford Lasers, Oxford) was
used to pump a dye laser that generated 630nm red light.
This was focused into a 1 mm diameter quartz fibre. The
diverging beam from this fibre was directed vertically down-
ward to produce a circular field of 3.5cm diameter at a
distance equivalent to that at which the centre of the tumour
would lie. The laser beam was not completely 'flat' normal
to the longitudinal axis, accordingly a relatively large beam
diameter was chosen in order to minimise inhomogeneities of
fluence across the approximately 1.5cm length of these
tumours. The power density of light at this distance was
adjusted to 100mWcm-2, as measured by a thermopile. The
light doses given were expressed in terms of fluence at this
distance, in Jcm-2. Unanaesthetised mice were placed prone
in a jig that protected the whole body other than the tumour
from the laser light. Single doses of 87.5-125Jcm-2 were
given. The vertical axis of the beam was marked on the skin
overlying the tumour and the mice were then housed under
subdued light for 24h.
NMR
Proton images of the tumours were obtained using a
'Biospec' system (Bruker/Oxford Research Systems,
Coventry), with a 4.7T, 15cm horizontal bore, magnet.
Animals were anaesthetised during imaging by an i.p.
inection of 0.1 ml of a 50mgml 1 solution of 'Ketalar'
(Parke-Davis, Pontypool) and positioned in the same perspex
holder that had been used for their irradiation by light. A
single turn surface coil (Ackerman et al., 1980) of 3 cm
diamater, was placed just above the tumour (Figure 1).
Images were acquired in the plane of the coil, using a spin
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Figure 1 Schematic of the imaging set-up (components not to
scale). The longitudinal axis ofprior laser illumination was in the
plane of the paper; the tumour which lay normal to the flank,
had been illuminated on its upper aspect; and the RF coil
overlay the tumour, again in the plane of the paper.
echo pulse sequence. A 90° 'hard' pulse of between 15 and
40ps duration was used, depending on the position of the
slice of interest relative to the plane of the coil. A frequency-
selective refocusing pulse of 6ms duration was used in a slice
selection gradient of 22mTm-1, to give a slice of lmm
thickness. This particular combination of pulses was used as,
in our hands, it avoided rapid changes in magnetic field
which can lead to artefacts in imaging. Repetition time (TR)
was 1.55s and echo delay time (TE) was 52ms. The overall
imaging time was 6min 36s for a 256 x 256 image, with in-
plane resolution of 120 x 120pm, for the 3.1 cm field of view.
To obtain T1 and T2 times, phase encoding was reduced to
128 steps. For measurement of T1, TE was 52ms and TR
was varied from 0.25 to 5.05 s in 4-6 steps, while for T2, TE
was varied from 52 to 142ms and TR was 5.00s. Values for
T1 and T2 were calculated from:
STR =SO( -eTR/TI), and STE =SOe-TEfr2,
where S=image intensity.
Histology
Immediately after NMR imaging, the mice were killed
painlessly by anaesthesia. The animals were anaesthetised
while still within the jigs in which they had been imaged, in
order to maintain the spatial relationships of the planes of
laser irradiation, imaging and histology. The tumour was
then partially bisected in the marked plane of irradiation, the
mouse removed from the jig, and the tumour dissected free
and fully bisected. The tumour was then fixed for histology,
using Bouin's fluid to prevent shrinkage. Three-pm thick
sections were made from the cut, equatorial faces of the
tumour halves and then stained with Haematoxylin and
Eosin.
Results
NMR
Proton images of T50/80 tumours that had received drug
alone or light alone were indistinguishable from those of
untreated control tumours, and were as shown in Figure 2.
The images just resolved the normal skin overlying the
tumour; the dark region between skin and tumour may be
the fibrous capsule that surrounds this neoplasm. Within the
tumour mass, the characteristically stippled appearance of
T50/80 images is believed to reflect the presence of numerous
discrete foci of 'old' coagulative necrosis (Figure 3c). NMR
images acquired 24h after PDT show clearly the effects of
therapy (Figure 3a). The peripheral bright area represents
the prompt oedema and inflammatory infiltration of the
dermis of the skin that is a common feature of external
treatments by PDT. On the side of the tumour closest to the
incident light beam, an area with high average signal inten-
Figure 2 NMR image of untreated T50/80 tumour. The thin
overlying skin is just resolved around the bottom right-hand
quadrant. Magnification x4.6.
sity could be distinguished from the image of the tumour
regions more remote from the beam (the latter more closely
resembling the images obtained from untreated controls; cf
Figures 2 and 3a).
Average values for the relaxation times T1 and T2 were
measured for areas of 1,200 x 1,200pm within (a) the oede-
matous dermis, (b) the high signal-intensity region of the
tumour nearest the light beam, (c) the lower-intensity region
remote from the beam. Two sites were sampled within each
region of each tumour and the data pooled. Values for
oedematous skin were significantly (P<0.05) higher than for
the tumour sites, with respect to both T1 and T2 measured
at 200MHz (Table I). In turn, values for the high-intensity
region of the tumour were significantly (P<0.05) higher than
those for the lower intensity region. Although statistically
significant, the differences in T1 and T2 between the two
regions of the tumour are insufficient of themselves to
account for the differences in the image intensities. For
image intensities given by: S=So(l- e-TR/T) (e-TE/T2), a %
contrast between necrotic and viable zones could be calcu-
lated by: 100 x(Sn-Sv)/Sv. Adopting the values for T1 and
T2 given in Table I, then for a TE of 52ms and TR of
1.552s the predicted % contrast is 15%, assuming equal
proton densities. However, the observed contrasts in image
intensity in the different tumours ranged from 23 to 44%.
Comparison of histological sections and NMR images
The object was to compare the appearance of an NMR
image with that of a section through the tumour with which
that image corresponded spatially. Accordingly, a uniform
method of analysis was adopted for both. Each coded
tumour section was scanned at right angles to the incident
light beam, at intervals of 0.4mm. For each position, and in
a plane corresponding to the vertical axis of the light beam,
measurement was made of the depth of tumour tissue
adjudged to have been wholly destroyed by PDT ('necrotic'
zone; Figure 3b). This was recognised as containing only
congested blood vessels and tumour cells with hyper-
chromatic, pyknotic or karyorrhectic nuclei, i.e. with no
histologically intact cells (defined as those with rounded
nuclei containing homogeneous heterochromatin). The inner
edge of the necrotic zone was defined as the depth at which
the first histologically intact cell was encountered in scanning
the plane (below which was the 'viable' zone; Figure 3c).
Twenty-five to 35 measurements were made per tumour.
Polaroid photographs of the NMR images were analysed
similarly. In this case, the 'necrotic' zone was defined as the
region of high signal intensity bounded by the tumour edge
nearest the incident light beam and extending a variable
distance into the tumour mass (Figure 3a).166 N.J.F. DODD et al.
The mean depth of necrosis in tumour sections rose from
2.75 to 4.5mm as the incident light dose was increased from
87.5 to 125Jcm-2. However, for a given dose there was a
large variation in depth of histological necrosis between
individual tumours (Figure 4a), and the differences between
means for increasing doses were statistically insignificant.
Thus, dose was a very poor predictor of PDT effect (using,
arbitrarily, a linear regression fit, r2=0.055). In contrast, a
plot of depth of histological necrosis as a function of depth
of NMR 'necrosis' could be described by the equation:
y=0.13 +0.93x, r2=0.95 (Figure 4b).
Discussion
For the particular combinations used here of drug dose,
drug-light interval, and power density of external illumina-
tion, there was a very wide variation in biological effect for a
given applied 'dose' of PDT. In an experimental system, it is
possible to optimise the different parameters to reduce some
of this variation; for example, since carrying out these initial
experiments, we have used extraction methods to show that
the amount of HPD that remains at 24h is widely variable
between tumours, but much less so at 6h (J.V. Moore, to be
published separately). In patients, such optimisation pro-
cedures are more difficult or even impossible, so that a non-
a
Figure 3 a, NMR image of T50/80 tumour treated 24h pre-
viously by HPD plus 112.5Jcm-2 of laser light, whose beam
direction was vertically downward in the plane of the image.
Shown in the image are oedematous dermal skin (D), the PDT-
damaged 'necrotic' zone (N) of the tumour, and the deeper
'viable' zone (V). Magnification x3.4. b, Light micrograph of
the histology of the tumour zone destroyed by PDT (cor-
responding spatially to image region 'N' in Figure 3a). The
junction of the tumour with its fibrotic capsule is shown (J). All
tumour cells are pyknotic (P) and the blood vessels congested
(B). Haematoxylin and Eosin staining. Magnification x85. c,
Light micrograph of the histology of the tumour zone spared in
the PDT treatment (corresponding spatially to image region 'V'
in Figure 3a). Shown are intact blood vessels (B), histologically
intact tumour cells (T), and 'old' coagulative necrosis (C). The
histology of untreated tumours is identical to this illustration. H
and E staining. Magnification x 85.
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Table I In vivo NMR relaxation times of tissues, in mice treated
24h previously by PDT
Tissue T1(s) T2(ms)
Oedematous dermis 2.10+0.10 a 111 + 16
'Necrotic' tumour 1.58+0.10 52+ 7
'Viable' tumour 1.31+0.11 41+ 2
aErrors as 1 s.d. for inter-animal variation (n =4).
Measured at 200MHz.
Figure 4 a, Depth of histological necrosis in T50/80 as a
function of light fluence on the tumour. Circles are mean values
for individual mice +2 s.e. (for 25-35 measurements per tumour;
intra-tumour variation). Where errors are not shown, they are
smaller than the symbol. Squares are mean depth of necrosis for
a given fluence +2 s.e. (for 3-5 mice; inter-tumour variation). b,
Depth of histological necrosis in T50/80 as a function of depth
of the high-signal-intensity zone in the corresponding NMR
image. Mean values +2 s.e. (for 25-35 measurements per
tumour). Line is the linear least-squares fit to the data.
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invasive method such as NMR for measuring the effect of a
treatment should be of clinical relevance.
Recently, 31p NMR spectroscopy has been used to detect
the early metabolic responses of tumours in vivo to PDT
(e.g. Ceckler et al., 1986; Naruse et al., 1986; Chopp et al.,
,1987). There is a decrease in ATP and increase in inorganic
phosphate within I h of treatment and continuing for several
hours thereafter. With sub-curative treatments, the tumour
ATP levels may recover to, or even exceed, that of controls.
Thus 31p NMR spectroscopy may be a useful method for
monitoring effects of PDT, but one that requires repeated
measurements and, as presently applied, one that gives
information only about the average metabolic state of the
tumour (and requires care, particularly with small tumours,
to exclude 'contamination' of results by underlying muscle).
Our results suggest that proton NMR imaging may provide
precise information on the extent of histological damage
resulting from a PDT treatment and by inference, on
whether further treatment would appear to be required.
However, these conclusions rest on a number of
assumptions:
(a) That the images do indeed distinguish lethally damaged
regions of tumours from 'viable' areas. There is a well-
established consensus that cells recognised as severely
pyknotic or karyorrhectic (Figure 3b) are reproductively
dead (although it does not follow that cells that are histo-
logically intact are necessarily reproductively viable). For the
mammary tumours examined here, the correlation between
histologically defined areas of tumour destruction and NMR
images, was good. Inspection of the two lower clusters of
points in Figure 4b suggests that for a given depth of NMR
'necrosis', the histological depth of necrosis might be greater
or less by up to 1 mm.
(b) That 24h is an appropriate time for comparison of
image and histology. Full time-course experiments are cur-
rently under way but it is known that the expression of
necrosis in tumour cells as a result of hypoxic or ischaemic
hypoxia occupies approximately 4-11 h (data from various
authors, summarised by Moore, 1987). One might therefore
expect that by 24h after PDT, the great majority of dead
cells would have expressed necrosis, while recovery processes
would not yet have occurred to a major extent (e.g. Star et
al., 1986; Kaye & Morstyn, 1987). As regards the NMR
images, we have noted that at 24h not only were T1 and T2
values increased in the 'necrotic' zone, but there was an
additional image contrast relative to the 'viable' zone.
Although the T1 and T2 values may be subject to revision on
more detailed measurement (e.g. the assumption of a single
exponential decay may be inappropriate), it is likely that this
high image contrast represents in part an increase in the
water content of the necrotic zone. It is characteristic of
PDT injury to tumour and normal tissue that oedema
develops promptly within the irradiated region, some 3-6h
after illumination (e.g. Berenbaum et al., 1986; Kaye &
Morstyn, 1987) and may peak at 1 or 2 days before
resolving (e.g. Moore et al., 1986; Star et al., 1986). The
choice of the same time, 24h, to measure both NMR
parameters and histology, seems not inappropriate.
(c) That measurement of depth of necrosis at early times is
relevant to therapeutic outcome. Brasseur et al. (1987) found
that the presence or absence of a strong necrotic reaction 3
days after PDT using a variety of drugs, predicted reason-
ably well the relative efficacy of the drugs in causing local
control of the EMT6 mammary tumour. More directly
relevant to the present experiments, Kinsey et al. (1983)
demonstrated for a murine mammary tumour that the
increasing radius of the necrotic zone, measured histo-
logically 2 days after interstitial laser illumination at progres-
sively higher power densities, corresponded with an increas-
ing delay in regrowth of similarly treated tumours. Using
non-invasive NMR imaging, it will be possible to test
definitively, for individual animals, the precise relationships
of early response and therapeutic outcome. Of particular
interest is that very preliminary results suggest that it may be
possible to obtain similar images using a low-field strength
clinical NMR machine (in our case, a 0.26T, 11 MHz, Picker
instrument).
N.J.F.D., J.V.M. and D.G.P. are supported by the Cancer Research
Campaign. The Biomedical NMR Unit is supported by the SERC.
References
ACKERMAN, J.J.H., GROVE, T.H., WONG, G.G., GADIAN, D.G. &
RADDA, G.K. (1980). Mapping of metabolites in whole animals
by 31p NMR using surface coils. Nature, 283, 167.
BENSTEAD, K. & MOORE, J.V. (1988). Vascular function and the
probability of skin necrosis after photodynamic therapy: an
experimental study. Br. J. Cancer, 57, 451.
BERENBAUM, M.C., HALL, G.W. & HOYES, A.D. (1986). Cerebral
photosensitisation by haematoporphyrin derivative. Evidence for
an endothelial site of action. Br. J. Cancer, 53, 81.
BRASSEUR, N., ALI, H., LANGLOIS, R., WAGNER, J.R., ROUSSEAU,
J. & VAN LIER, J.E. (1987). Biologic activities of phthalocyanines.
V. Photodynamic therapy of EMT-6 mammary tumours in mice
with sulphonated phthalocyanines. Photochem. Photobiol., 45,
581.
CECKLER, T.L., BRYANT, R.G., PENNEY, D.P., GIBSON, S.L. & HILF,
R. (1986). 3IP-NMR spectroscopy demonstrates decreased ATP
levels in vivo as an early response to photodynamic therapy.
Biochem. Biophys. Res. Commun., 140, 273.
CHOPP, M., FARMER, H., HETZEL, F. & SCHAPP, A.P. (1987). In vivo
31P-NMR spectroscopy of mammary carcinoma subjected to
subcurative photodynamic therapy. Photochem. Photobiol., 46,
819.
HENDERSON, B., WALDOW, S.M., MANG, T.S., POTTER, W.R.,
MALONE, P.B. & DOUGHERTY, T.J. (1985). Tumour destruction
and kinetics of tumour cell death in two experimental mouse
tumours following photodynamic therapy. Cancer Res., 45, 572.
KAYE, A.H. & MORSTYN, G. (1987). Photoradiation therapy causing
selective tumour kill in a rat glioma model. Neurosurgery, 20,
408.
KERR, J.F.R., SEARLE, J., HARMON, B.V. & BISHOP, C.J. (1987).
Apoptosis. In Perspectives on Mammalian Cell Death, Potten,
C.S. (ed.) p. 93. Oxford University Press: Oxford.
KINSEY, J.H., CORTESE, D.A. & NEEL, H.B. (1983). Thermal con-
siderations in murine tumour killing using haematoporphyrin
derivative phototherapy. Cancer Res., 43, 1562.
MOORE, J.V. (1987). Death of cells and necrosis of tumours. In
Perspectives on Mammalian Cell Death, Potten, C.S. (ed.) p. 295.
Oxford University Press: Oxford.
MOORE, J.V., KEENE, J.P. & LAND, E.J. (1986). Dose-response
relationships for photodynamic injury to murine skin. Br. J.
Radiol., 59, 257.
NARUSE, S., HORIKAWA, Y., TANAKA, C. and 4 others (1986).
Evaluation of the effects of photoradiation therapy on brain
tumours with in vivo 31p MR spectroscopy. Radiology, 160, 827.
STAR, W.M., MARIJNISSEN, H.P.A., VAN DEN BERG-BLOK, A.E.,
VERSTEEG, J.A.C., FRANKEN, K.A.P. & REINHOLD, H.S. (1986).
Destruction of rat mammary tumour and normal tissue micro-
circulation by haematoporphyrin derivative photoradiation
observed in vivo in sandwich observation chambers. Cancer Res.,
46, 2532.
TRUMP, B.F. & ARSTILA, A.U. (1975). Cellular reaction to injury. In
Principles of Pathobiology, Lavin, M.F. & Hill, R.B. (ed.) p. 9.
Oxford University Press: Oxford.